Compare AbCellera Biologics Inc (ABCL) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Twilio Inc — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Twilio Inc trades at $254.16 (market cap $39.31B). The key difference: Twilio Inc is far larger — about 13.1× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.
| ABCL | TWLO | |
|---|---|---|
Market Cap | $2.99B | $39.31B |
Sector | Health | Technology |
52-Week High | $9.76 | $255.95 |
52-Week Low | $2.78 | $95.23 |
Enterprise Value | $2.58B | $37.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
